Associated Papers
Clinical implications of genetic variation in carboxylesterase drug metabolism.
Chen F et al.
Expert Opinion on Drug Metabolism & Toxicology, 2018
Pharmacogenetic pathway analysis of irinotecan.
Rosner GL et al.
Clinical Pharmacology and Therapeutics, 2008
Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.
Wu MH et al.
Pharmacogenetics, 2004
Select a paper to view details